Table 4.

RR (95% CI) of pancreatic cancer according to ALT and AST levels excluding 2, 4, 6, 8, and 10 years of follow-up

No. years of follow-up excluded
2
4
6
8
10
CasesRR* (95% CI)CasesRR* (95% CI)CasesRR* (95% CI)CasesRR* (95% CI)CasesRR* (95% CI)
AST
    <205781.004941.003921.002761.001371.00
    20-309761.00 (0.90-1.11)8471.02 (0.91-1.14)6691.02 (0.90-1.16)4601.00 (0.86-1.16)2451.09 (0.88-1.34)
    30-404121.19 (1.05-1.35)3361.14 (0.99-1.31)2581.11 (0.95-1.31)1751.08 (0.89-1.31)8321.04 (0.79-1.37)
    40+2241.33 (1.14-1.55)1951.36 (1.15-1.61)1361.22 (1.01-1.49)891.16 (0.91-1.48)451.21 (0.86-1.70)
Ptrend0.050.060.040.050.17
ALT
    <209751.008451.006621.004351.002231.00
    20-307081.06 (0.96-1.16)6021.03 (0.92-1.14)4651.01 (0.89-1.13)3321.08 (0.94-1.25)1661.01 (0.83-1.24)
    30-402731.19 (1.04-1.36)2251.12 (0.96-1.30)1741.09 (0.92-1.29)1261.19 (0.97-1.45)631.10 (0.83-1.46)
    40+2341.34 (1.16-1.56)2001.31 (1.12-1.54)1541.28 (1.07-1.53)1071.34 (1.08-1.67)581.36 (1.01-1.83)
Ptrend2000.020.060.090.010.10
  • * Adjusted for age, gender, body mass index, smoking, and fasting serum glucose levels.